Company / EPS (Diluted)
Bruker EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$2.90
FY2025
5-year range
$1.02 / $2.90
FY2021-FY2025
Trend
+45.7%
vs FY2024
Sector context
#48 of 159
Health Care
What the data says
At $2.90, Bruker's eps (diluted) ranks #48 of 159 in the Health Care sector. EPS (Diluted) has increased for 3 consecutive years, from $1.02 in FY2022 to $2.90 in FY2025.
Based on SEC 10-K filings.
2.90 in FY2025 with a 5-year CAGR of +20.5%.
Improved from $1.81 to $2.90 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +41.7%
- 5-Year CAGR
- +20.5%
- 10-Year CAGR
- -
Sector benchmark
#48 of 159 in Health CareTop 30% of 159This company $2.90 Sector average $1.66
▼
+75.2% above sector average
Key checks
Key Insights
- Bruker's eps (diluted) has grown for 3 consecutive years.
- In FY2025, eps (diluted) increased 45.7% year-over-year.
- Ranks #48 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2016.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.90 | +45.7% |
| FY2024 | $1.99 | +9.9% |
| FY2023 | $1.81 | +77.5% |
| FY2022 | $1.02 | -19.0% |
| FY2021 | $1.26 | +10.5% |
| FY2020 | $1.14 | +132.7% |
| FY2019 | $0.49 | -48.4% |
| FY2018 | $0.95 | +58.3% |
| FY2017 | $0.60 | +81.8% |
| FY2016 | $0.33 | -31.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026